Bioventus Inc
NASDAQ:BVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bioventus Inc
NASDAQ:BVS
|
US |
|
F
|
FnGuide Inc
KOSDAQ:064850
|
KR |
|
I
|
IntriEnergy Inc
OTC:ITRE
|
US |
|
R
|
Resona Holdings Inc
XMUN:DW1
|
JP |
|
G
|
Gnomestar Craft Inc
CNSX:GNOM
|
CA |
|
B
|
Binh Duong Trade and Development JSC
VN:TDC
|
VN |
|
Southern First Bancshares Inc
NASDAQ:SFST
|
US |
Wall St Price Targets
BVS Price Targets Summary
Bioventus Inc
According to Wall Street analysts, the average 1-year price target for BVS is 17.95 USD with a low forecast of 15.15 USD and a high forecast of 19.95 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BVS's stock price target?
Price Target
17.95
USD
According to Wall Street analysts, the average 1-year price target for BVS is 17.95 USD with a low forecast of 15.15 USD and a high forecast of 19.95 USD.
What is the Revenue forecast for Bioventus Inc?
Projected CAGR
7%
Over the last 11 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 7%.
What is the Gross Profit forecast for Bioventus Inc?
Projected CAGR
8%
Over the last 11 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 5 years is 8%.
What is the Operating Income forecast for Bioventus Inc?
Projected CAGR
21%
The compound annual growth rate for Operating Income over the next 3 years is 21%.
What is the Pre-Tax Income forecast for Bioventus Inc?
Projected CAGR
39%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 39%.
What is the Net Income forecast for Bioventus Inc?
Projected CAGR
49%
The compound annual growth rate for Net Income over the next 3 years is 49%.
